Application 040568
- Type
- ANDA
- Sponsor
- RENATA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLYCOPYRROLATE | GLYCOPYRROLATE | TABLET;ORAL | 1MG | No | No |
| 002 | GLYCOPYRROLATE | GLYCOPYRROLATE | TABLET;ORAL | 2MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040568-001 | GLYCOPYRROLATE | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | ||
| A040568-002 | GLYCOPYRROLATE | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A040568-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | 2004-12-22 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A040568-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | 2004-12-22 | 3bdfa0b2c4d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 987ba524-361e-49c3-9e00-550a78748542 | 2026-11-09 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | d93a9b2b-708d-4db5-8aae-45fd3a7ca65c | 2026-11-05 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | fcb295e4-038f-4d4f-8786-4fbcd1d3c298 | 2026-11-02 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 74d51ba3-0ca0-4a04-aa87-1c243f885bd8 | 2026-11-02 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 8b4d1798-c0a7-4661-99cd-1e9a23c16386 | 2026-10-30 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 48a8356e-377e-45ef-a1bf-e9ffec051749 | 2026-10-26 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 83602e34-7a8c-4606-b43e-23ab909b6c1a | 2026-10-19 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Meitheal Pharmaceuticals Inc. | 02541cfd-b209-49b9-a73f-13ef18dce06d | 2026-10-19 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate Oral Solution | GLYCOPYRROLATE | Granules Pharmaceuticals Inc. | 0f05c5d3-9c41-4dae-88d1-18cbddc69487 | 2026-10-08 | Warnings, Adverse reactions | GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | REMEDYREPACK INC. | 5d7a742e-2bcf-4db4-a07c-f669938e4068 | 2026-09-16 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | QUAGEN PHARMACEUTICALS LLC | 62e1ba35-bc84-4818-be54-8b534a1bf93c | 2026-09-10 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | f7187ddb-ea11-4aa8-8215-a5fcf0f1ca7c | 2026-09-09 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Henry Schein, Inc. | 4ecb3435-58e5-46cb-b8c2-85b5fd955f83 | 2026-09-09 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Solco Healthcare US, LLC | 2972f22e-378c-450b-8869-1354a9bd0ffc | 2026-07-23 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Solco Healthcare US, LLC | 3707f06a-6cba-4f5c-86ab-fb95bc2a933c | 2026-07-23 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Par Health USA, LLC | 1f266d77-4f9e-44c9-a000-2f8fea3ac80b | 2026-07-09 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Amneal Pharmaceuticals LLC | bbab4cf1-0441-4fc4-9de9-e4117fa19faa | 2026-07-07 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Piramal Critical Care Inc | 83d70378-011b-4ce3-e053-2991aa0a22be | 2026-06-23 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Cardinal Health 107, LLC | 65688bed-0d70-4b51-8301-1948b1deade1 | 2026-06-02 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | REMEDYREPACK INC. | 220cd5f5-3d71-4fdb-9943-7468799c179f | 2026-06-02 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.